nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0468	0.12	CbGbCtD
Atomoxetine—CYP2C19—Prednisone—rheumatoid arthritis	0.0432	0.111	CbGbCtD
Atomoxetine—CYP2C19—Cyclosporine—rheumatoid arthritis	0.041	0.105	CbGbCtD
Atomoxetine—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0345	0.0886	CbGbCtD
Atomoxetine—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0311	0.08	CbGbCtD
Atomoxetine—CYP2C19—Dexamethasone—rheumatoid arthritis	0.027	0.0693	CbGbCtD
Atomoxetine—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0261	0.0671	CbGbCtD
Atomoxetine—CYP3A4—Betamethasone—rheumatoid arthritis	0.0224	0.0576	CbGbCtD
Atomoxetine—CYP3A4—Prednisolone—rheumatoid arthritis	0.0221	0.0568	CbGbCtD
Atomoxetine—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.021	0.0539	CbGbCtD
Atomoxetine—CYP3A4—Prednisone—rheumatoid arthritis	0.0209	0.0537	CbGbCtD
Atomoxetine—CYP2D6—Dexamethasone—rheumatoid arthritis	0.0205	0.0527	CbGbCtD
Atomoxetine—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0198	0.0509	CbGbCtD
Atomoxetine—CYP3A4—Dexamethasone—rheumatoid arthritis	0.013	0.0335	CbGbCtD
Atomoxetine—Pseudoephedrine—NFATC1—rheumatoid arthritis	0.0054	0.459	CrCbGaD
Atomoxetine—Pseudoephedrine—IL2—rheumatoid arthritis	0.00188	0.16	CrCbGaD
Atomoxetine—Ketoprofen—CXCL8—rheumatoid arthritis	0.000836	0.0711	CrCbGaD
Atomoxetine—Desipramine—SLC22A4—rheumatoid arthritis	0.000685	0.0583	CrCbGaD
Atomoxetine—Pseudoephedrine—TNF—rheumatoid arthritis	0.000634	0.0539	CrCbGaD
Atomoxetine—Fenoprofen—PTGS2—rheumatoid arthritis	0.000413	0.0352	CrCbGaD
Atomoxetine—Fenoprofen—ALB—rheumatoid arthritis	0.000368	0.0313	CrCbGaD
Atomoxetine—Vertigo—Betamethasone—rheumatoid arthritis	0.000349	0.00084	CcSEcCtD
Atomoxetine—Syncope—Dexamethasone—rheumatoid arthritis	0.000348	0.000839	CcSEcCtD
Atomoxetine—Syncope—Betamethasone—rheumatoid arthritis	0.000348	0.000839	CcSEcCtD
Atomoxetine—Infection—Triamcinolone—rheumatoid arthritis	0.000347	0.000836	CcSEcCtD
Atomoxetine—Infection—Methylprednisolone—rheumatoid arthritis	0.000346	0.000834	CcSEcCtD
Atomoxetine—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000344	0.000828	CcSEcCtD
Atomoxetine—Vomiting—Leflunomide—rheumatoid arthritis	0.000343	0.000828	CcSEcCtD
Atomoxetine—Shock—Triamcinolone—rheumatoid arthritis	0.000343	0.000827	CcSEcCtD
Atomoxetine—Insomnia—Prednisolone—rheumatoid arthritis	0.000343	0.000827	CcSEcCtD
Atomoxetine—Shock—Methylprednisolone—rheumatoid arthritis	0.000343	0.000826	CcSEcCtD
Atomoxetine—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000341	0.000823	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000341	0.000822	CcSEcCtD
Atomoxetine—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000341	0.000822	CcSEcCtD
Atomoxetine—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000341	0.000822	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000341	0.000821	CcSEcCtD
Atomoxetine—Rash—Leflunomide—rheumatoid arthritis	0.000341	0.000821	CcSEcCtD
Atomoxetine—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000341	0.000821	CcSEcCtD
Atomoxetine—Dermatitis—Leflunomide—rheumatoid arthritis	0.00034	0.00082	CcSEcCtD
Atomoxetine—Mental disorder—Prednisone—rheumatoid arthritis	0.00034	0.00082	CcSEcCtD
Atomoxetine—Nausea—Azathioprine—rheumatoid arthritis	0.00034	0.000819	CcSEcCtD
Atomoxetine—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.00034	0.000819	CcSEcCtD
Atomoxetine—Headache—Leflunomide—rheumatoid arthritis	0.000338	0.000816	CcSEcCtD
Atomoxetine—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000338	0.000815	CcSEcCtD
Atomoxetine—Malnutrition—Prednisone—rheumatoid arthritis	0.000338	0.000814	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000338	0.000814	CcSEcCtD
Atomoxetine—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000337	0.000813	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000337	0.000811	CcSEcCtD
Atomoxetine—Convulsion—Betamethasone—rheumatoid arthritis	0.000336	0.00081	CcSEcCtD
Atomoxetine—Convulsion—Dexamethasone—rheumatoid arthritis	0.000336	0.00081	CcSEcCtD
Atomoxetine—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000335	0.000808	CcSEcCtD
Atomoxetine—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000333	0.000802	CcSEcCtD
Atomoxetine—Urticaria—Cyclosporine—rheumatoid arthritis	0.000331	0.000798	CcSEcCtD
Atomoxetine—Myalgia—Dexamethasone—rheumatoid arthritis	0.00033	0.000796	CcSEcCtD
Atomoxetine—Myalgia—Betamethasone—rheumatoid arthritis	0.00033	0.000796	CcSEcCtD
Atomoxetine—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.00033	0.000794	CcSEcCtD
Atomoxetine—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.00033	0.000794	CcSEcCtD
Atomoxetine—Anxiety—Dexamethasone—rheumatoid arthritis	0.000329	0.000793	CcSEcCtD
Atomoxetine—Anxiety—Betamethasone—rheumatoid arthritis	0.000329	0.000793	CcSEcCtD
Atomoxetine—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000326	0.000786	CcSEcCtD
Atomoxetine—Pain—Prednisolone—rheumatoid arthritis	0.000324	0.000782	CcSEcCtD
Atomoxetine—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000322	0.000776	CcSEcCtD
Atomoxetine—Nausea—Leflunomide—rheumatoid arthritis	0.000321	0.000774	CcSEcCtD
Atomoxetine—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.00032	0.000772	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.00032	0.000771	CcSEcCtD
Atomoxetine—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000319	0.00077	CcSEcCtD
Atomoxetine—Vision blurred—Prednisone—rheumatoid arthritis	0.000318	0.000767	CcSEcCtD
Atomoxetine—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000318	0.000766	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000318	0.000766	CcSEcCtD
Atomoxetine—Phenprocoumon—ALB—rheumatoid arthritis	0.000318	0.027	CrCbGaD
Atomoxetine—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000317	0.000765	CcSEcCtD
Atomoxetine—Pain—Hydrocortisone—rheumatoid arthritis	0.000317	0.000764	CcSEcCtD
Atomoxetine—Insomnia—Triamcinolone—rheumatoid arthritis	0.000316	0.000761	CcSEcCtD
Atomoxetine—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000315	0.000759	CcSEcCtD
Atomoxetine—Infection—Dexamethasone—rheumatoid arthritis	0.000315	0.000758	CcSEcCtD
Atomoxetine—Infection—Betamethasone—rheumatoid arthritis	0.000315	0.000758	CcSEcCtD
Atomoxetine—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000313	0.000755	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000313	0.000754	CcSEcCtD
Atomoxetine—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000313	0.000754	CcSEcCtD
Atomoxetine—Shock—Betamethasone—rheumatoid arthritis	0.000311	0.000751	CcSEcCtD
Atomoxetine—Shock—Dexamethasone—rheumatoid arthritis	0.000311	0.000751	CcSEcCtD
Atomoxetine—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.00031	0.000748	CcSEcCtD
Atomoxetine—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.00031	0.000748	CcSEcCtD
Atomoxetine—Agitation—Prednisone—rheumatoid arthritis	0.00031	0.000748	CcSEcCtD
Atomoxetine—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000309	0.000745	CcSEcCtD
Atomoxetine—Tachycardia—Betamethasone—rheumatoid arthritis	0.000309	0.000745	CcSEcCtD
Atomoxetine—Fluoxetine—ALB—rheumatoid arthritis	0.000309	0.0263	CrCbGaD
Atomoxetine—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000307	0.00074	CcSEcCtD
Atomoxetine—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000306	0.000739	CcSEcCtD
Atomoxetine—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000306	0.000738	CcSEcCtD
Atomoxetine—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000306	0.000738	CcSEcCtD
Atomoxetine—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000305	0.000736	CcSEcCtD
Atomoxetine—Vertigo—Prednisone—rheumatoid arthritis	0.000304	0.000732	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000303	0.00073	CcSEcCtD
Atomoxetine—Syncope—Prednisone—rheumatoid arthritis	0.000303	0.00073	CcSEcCtD
Atomoxetine—Anorexia—Betamethasone—rheumatoid arthritis	0.000302	0.000727	CcSEcCtD
Atomoxetine—Anorexia—Dexamethasone—rheumatoid arthritis	0.000302	0.000727	CcSEcCtD
Atomoxetine—Urticaria—Prednisolone—rheumatoid arthritis	0.000301	0.000727	CcSEcCtD
Atomoxetine—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000301	0.000726	CcSEcCtD
Atomoxetine—Fatigue—Triamcinolone—rheumatoid arthritis	0.000301	0.000725	CcSEcCtD
Atomoxetine—Fatigue—Methylprednisolone—rheumatoid arthritis	0.0003	0.000723	CcSEcCtD
Atomoxetine—Asthenia—Cyclosporine—rheumatoid arthritis	0.000299	0.000721	CcSEcCtD
Atomoxetine—Pain—Triamcinolone—rheumatoid arthritis	0.000298	0.000719	CcSEcCtD
Atomoxetine—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000297	0.000716	CcSEcCtD
Atomoxetine—Pruritus—Cyclosporine—rheumatoid arthritis	0.000295	0.000711	CcSEcCtD
Atomoxetine—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000294	0.00071	CcSEcCtD
Atomoxetine—Angiopathy—Methotrexate—rheumatoid arthritis	0.000294	0.000709	CcSEcCtD
Atomoxetine—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000293	0.000706	CcSEcCtD
Atomoxetine—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000293	0.000706	CcSEcCtD
Atomoxetine—Convulsion—Prednisone—rheumatoid arthritis	0.000293	0.000706	CcSEcCtD
Atomoxetine—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000292	0.000705	CcSEcCtD
Atomoxetine—Chills—Methotrexate—rheumatoid arthritis	0.000291	0.000701	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000288	0.000695	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000288	0.000695	CcSEcCtD
Atomoxetine—Myalgia—Prednisone—rheumatoid arthritis	0.000288	0.000693	CcSEcCtD
Atomoxetine—Arthralgia—Prednisone—rheumatoid arthritis	0.000288	0.000693	CcSEcCtD
Atomoxetine—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000288	0.000693	CcSEcCtD
Atomoxetine—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000287	0.000692	CcSEcCtD
Atomoxetine—Anxiety—Prednisone—rheumatoid arthritis	0.000287	0.000691	CcSEcCtD
Atomoxetine—Insomnia—Betamethasone—rheumatoid arthritis	0.000286	0.00069	CcSEcCtD
Atomoxetine—Insomnia—Dexamethasone—rheumatoid arthritis	0.000286	0.00069	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000286	0.000688	CcSEcCtD
Atomoxetine—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000285	0.000688	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000285	0.000686	CcSEcCtD
Atomoxetine—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000284	0.000685	CcSEcCtD
Atomoxetine—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000284	0.000685	CcSEcCtD
Atomoxetine—Mental disorder—Methotrexate—rheumatoid arthritis	0.000284	0.000685	CcSEcCtD
Atomoxetine—Malnutrition—Methotrexate—rheumatoid arthritis	0.000282	0.000681	CcSEcCtD
Atomoxetine—Warfarin—ALB—rheumatoid arthritis	0.000282	0.024	CrCbGaD
Atomoxetine—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000279	0.000672	CcSEcCtD
Atomoxetine—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000279	0.000672	CcSEcCtD
Atomoxetine—Urticaria—Triamcinolone—rheumatoid arthritis	0.000277	0.000668	CcSEcCtD
Atomoxetine—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000277	0.000667	CcSEcCtD
Atomoxetine—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000276	0.000666	CcSEcCtD
Atomoxetine—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000276	0.000665	CcSEcCtD
Atomoxetine—Dizziness—Cyclosporine—rheumatoid arthritis	0.000276	0.000665	CcSEcCtD
Atomoxetine—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000275	0.000663	CcSEcCtD
Atomoxetine—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000275	0.000663	CcSEcCtD
Atomoxetine—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000275	0.000663	CcSEcCtD
Atomoxetine—Infection—Prednisone—rheumatoid arthritis	0.000274	0.00066	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000273	0.000659	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000273	0.000659	CcSEcCtD
Atomoxetine—Back pain—Methotrexate—rheumatoid arthritis	0.000273	0.000658	CcSEcCtD
Atomoxetine—Fatigue—Dexamethasone—rheumatoid arthritis	0.000273	0.000658	CcSEcCtD
Atomoxetine—Fatigue—Betamethasone—rheumatoid arthritis	0.000273	0.000658	CcSEcCtD
Atomoxetine—Shock—Prednisone—rheumatoid arthritis	0.000271	0.000654	CcSEcCtD
Atomoxetine—Pain—Dexamethasone—rheumatoid arthritis	0.000271	0.000653	CcSEcCtD
Atomoxetine—Pain—Betamethasone—rheumatoid arthritis	0.000271	0.000653	CcSEcCtD
Atomoxetine—Nervous system disorder—Prednisone—rheumatoid arthritis	0.00027	0.000652	CcSEcCtD
Atomoxetine—Tachycardia—Prednisone—rheumatoid arthritis	0.000269	0.000649	CcSEcCtD
Atomoxetine—Skin disorder—Prednisone—rheumatoid arthritis	0.000268	0.000646	CcSEcCtD
Atomoxetine—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000267	0.000642	CcSEcCtD
Atomoxetine—Vision blurred—Methotrexate—rheumatoid arthritis	0.000266	0.000641	CcSEcCtD
Atomoxetine—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000266	0.000641	CcSEcCtD
Atomoxetine—Vomiting—Cyclosporine—rheumatoid arthritis	0.000265	0.000639	CcSEcCtD
Atomoxetine—Rash—Cyclosporine—rheumatoid arthritis	0.000263	0.000634	CcSEcCtD
Atomoxetine—Anorexia—Prednisone—rheumatoid arthritis	0.000263	0.000633	CcSEcCtD
Atomoxetine—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000263	0.000633	CcSEcCtD
Atomoxetine—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000262	0.000632	CcSEcCtD
Atomoxetine—Headache—Cyclosporine—rheumatoid arthritis	0.000261	0.00063	CcSEcCtD
Atomoxetine—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000261	0.000629	CcSEcCtD
Atomoxetine—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000261	0.000629	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000259	0.000624	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000259	0.000624	CcSEcCtD
Atomoxetine—Vertigo—Methotrexate—rheumatoid arthritis	0.000254	0.000611	CcSEcCtD
Atomoxetine—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000254	0.000611	CcSEcCtD
Atomoxetine—Urticaria—Betamethasone—rheumatoid arthritis	0.000251	0.000606	CcSEcCtD
Atomoxetine—Urticaria—Dexamethasone—rheumatoid arthritis	0.000251	0.000606	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000251	0.000605	CcSEcCtD
Atomoxetine—Dizziness—Prednisolone—rheumatoid arthritis	0.000251	0.000605	CcSEcCtD
Atomoxetine—Asthenia—Triamcinolone—rheumatoid arthritis	0.00025	0.000603	CcSEcCtD
Atomoxetine—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.00025	0.000603	CcSEcCtD
Atomoxetine—Abdominal pain—Betamethasone—rheumatoid arthritis	0.00025	0.000603	CcSEcCtD
Atomoxetine—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.00025	0.000603	CcSEcCtD
Atomoxetine—Body temperature increased—Betamethasone—rheumatoid arthritis	0.00025	0.000603	CcSEcCtD
Atomoxetine—Asthenia—Methylprednisolone—rheumatoid arthritis	0.00025	0.000602	CcSEcCtD
Atomoxetine—Insomnia—Prednisone—rheumatoid arthritis	0.000249	0.000601	CcSEcCtD
Atomoxetine—Nausea—Cyclosporine—rheumatoid arthritis	0.000248	0.000597	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisone—rheumatoid arthritis	0.000248	0.000597	CcSEcCtD
Atomoxetine—Pruritus—Triamcinolone—rheumatoid arthritis	0.000247	0.000595	CcSEcCtD
Atomoxetine—Cough—Methotrexate—rheumatoid arthritis	0.000246	0.000594	CcSEcCtD
Atomoxetine—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000246	0.000594	CcSEcCtD
Atomoxetine—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000245	0.000591	CcSEcCtD
Atomoxetine—Convulsion—Methotrexate—rheumatoid arthritis	0.000245	0.00059	CcSEcCtD
Atomoxetine—Ketoprofen—PTGS2—rheumatoid arthritis	0.000244	0.0208	CrCbGaD
Atomoxetine—Dyspepsia—Prednisone—rheumatoid arthritis	0.000243	0.000585	CcSEcCtD
Atomoxetine—Myalgia—Methotrexate—rheumatoid arthritis	0.00024	0.000579	CcSEcCtD
Atomoxetine—Chest pain—Methotrexate—rheumatoid arthritis	0.00024	0.000579	CcSEcCtD
Atomoxetine—Arthralgia—Methotrexate—rheumatoid arthritis	0.00024	0.000579	CcSEcCtD
Atomoxetine—Decreased appetite—Prednisone—rheumatoid arthritis	0.00024	0.000578	CcSEcCtD
Atomoxetine—Rash—Prednisolone—rheumatoid arthritis	0.000239	0.000577	CcSEcCtD
Atomoxetine—Dermatitis—Prednisolone—rheumatoid arthritis	0.000239	0.000576	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000239	0.000575	CcSEcCtD
Atomoxetine—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000238	0.000574	CcSEcCtD
Atomoxetine—Fatigue—Prednisone—rheumatoid arthritis	0.000238	0.000573	CcSEcCtD
Atomoxetine—Headache—Prednisolone—rheumatoid arthritis	0.000238	0.000573	CcSEcCtD
Atomoxetine—Constipation—Prednisone—rheumatoid arthritis	0.000236	0.000568	CcSEcCtD
Atomoxetine—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000236	0.000568	CcSEcCtD
Atomoxetine—Rash—Hydrocortisone—rheumatoid arthritis	0.000234	0.000563	CcSEcCtD
Atomoxetine—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000233	0.000563	CcSEcCtD
Atomoxetine—Headache—Hydrocortisone—rheumatoid arthritis	0.000232	0.00056	CcSEcCtD
Atomoxetine—Dizziness—Triamcinolone—rheumatoid arthritis	0.000231	0.000556	CcSEcCtD
Atomoxetine—Dizziness—Methylprednisolone—rheumatoid arthritis	0.00023	0.000555	CcSEcCtD
Atomoxetine—Infection—Methotrexate—rheumatoid arthritis	0.000229	0.000552	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000227	0.000548	CcSEcCtD
Atomoxetine—Asthenia—Betamethasone—rheumatoid arthritis	0.000227	0.000548	CcSEcCtD
Atomoxetine—Asthenia—Dexamethasone—rheumatoid arthritis	0.000227	0.000548	CcSEcCtD
Atomoxetine—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000226	0.000545	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000225	0.000543	CcSEcCtD
Atomoxetine—Nausea—Prednisolone—rheumatoid arthritis	0.000225	0.000543	CcSEcCtD
Atomoxetine—Pruritus—Betamethasone—rheumatoid arthritis	0.000224	0.00054	CcSEcCtD
Atomoxetine—Pruritus—Dexamethasone—rheumatoid arthritis	0.000224	0.00054	CcSEcCtD
Atomoxetine—Skin disorder—Methotrexate—rheumatoid arthritis	0.000224	0.000539	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000223	0.000537	CcSEcCtD
Atomoxetine—Vomiting—Triamcinolone—rheumatoid arthritis	0.000222	0.000535	CcSEcCtD
Atomoxetine—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000221	0.000534	CcSEcCtD
Atomoxetine—Nausea—Hydrocortisone—rheumatoid arthritis	0.00022	0.000531	CcSEcCtD
Atomoxetine—Rash—Triamcinolone—rheumatoid arthritis	0.00022	0.00053	CcSEcCtD
Atomoxetine—Dermatitis—Triamcinolone—rheumatoid arthritis	0.00022	0.00053	CcSEcCtD
Atomoxetine—Anorexia—Methotrexate—rheumatoid arthritis	0.00022	0.000529	CcSEcCtD
Atomoxetine—Rash—Methylprednisolone—rheumatoid arthritis	0.00022	0.000529	CcSEcCtD
Atomoxetine—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000219	0.000529	CcSEcCtD
Atomoxetine—Urticaria—Prednisone—rheumatoid arthritis	0.000219	0.000528	CcSEcCtD
Atomoxetine—Headache—Triamcinolone—rheumatoid arthritis	0.000219	0.000527	CcSEcCtD
Atomoxetine—Headache—Methylprednisolone—rheumatoid arthritis	0.000218	0.000526	CcSEcCtD
Atomoxetine—Abdominal pain—Prednisone—rheumatoid arthritis	0.000218	0.000525	CcSEcCtD
Atomoxetine—Body temperature increased—Prednisone—rheumatoid arthritis	0.000218	0.000525	CcSEcCtD
Atomoxetine—Ketoprofen—ALB—rheumatoid arthritis	0.000217	0.0185	CrCbGaD
Atomoxetine—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000217	0.000522	CcSEcCtD
Atomoxetine—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000217	0.000522	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.00021	0.000506	CcSEcCtD
Atomoxetine—Dizziness—Betamethasone—rheumatoid arthritis	0.000209	0.000505	CcSEcCtD
Atomoxetine—Dizziness—Dexamethasone—rheumatoid arthritis	0.000209	0.000505	CcSEcCtD
Atomoxetine—Insomnia—Methotrexate—rheumatoid arthritis	0.000208	0.000502	CcSEcCtD
Atomoxetine—Nausea—Triamcinolone—rheumatoid arthritis	0.000207	0.0005	CcSEcCtD
Atomoxetine—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000207	0.000499	CcSEcCtD
Atomoxetine—Nausea—Methylprednisolone—rheumatoid arthritis	0.000207	0.000498	CcSEcCtD
Atomoxetine—Somnolence—Methotrexate—rheumatoid arthritis	0.000205	0.000494	CcSEcCtD
Atomoxetine—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000203	0.000489	CcSEcCtD
Atomoxetine—Vomiting—Betamethasone—rheumatoid arthritis	0.000201	0.000485	CcSEcCtD
Atomoxetine—Vomiting—Dexamethasone—rheumatoid arthritis	0.000201	0.000485	CcSEcCtD
Atomoxetine—Decreased appetite—Methotrexate—rheumatoid arthritis	0.0002	0.000483	CcSEcCtD
Atomoxetine—Rash—Dexamethasone—rheumatoid arthritis	0.0002	0.000481	CcSEcCtD
Atomoxetine—Rash—Betamethasone—rheumatoid arthritis	0.0002	0.000481	CcSEcCtD
Atomoxetine—Dermatitis—Betamethasone—rheumatoid arthritis	0.000199	0.000481	CcSEcCtD
Atomoxetine—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000199	0.000481	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000199	0.00048	CcSEcCtD
Atomoxetine—Fatigue—Methotrexate—rheumatoid arthritis	0.000199	0.000479	CcSEcCtD
Atomoxetine—Headache—Dexamethasone—rheumatoid arthritis	0.000198	0.000478	CcSEcCtD
Atomoxetine—Headache—Betamethasone—rheumatoid arthritis	0.000198	0.000478	CcSEcCtD
Atomoxetine—Asthenia—Prednisone—rheumatoid arthritis	0.000198	0.000477	CcSEcCtD
Atomoxetine—Pain—Methotrexate—rheumatoid arthritis	0.000197	0.000475	CcSEcCtD
Atomoxetine—Pruritus—Prednisone—rheumatoid arthritis	0.000195	0.00047	CcSEcCtD
Atomoxetine—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.00019	0.000458	CcSEcCtD
Atomoxetine—Diarrhoea—Prednisone—rheumatoid arthritis	0.000189	0.000455	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000188	0.000454	CcSEcCtD
Atomoxetine—Nausea—Betamethasone—rheumatoid arthritis	0.000188	0.000453	CcSEcCtD
Atomoxetine—Nausea—Dexamethasone—rheumatoid arthritis	0.000188	0.000453	CcSEcCtD
Atomoxetine—Urticaria—Methotrexate—rheumatoid arthritis	0.000183	0.000441	CcSEcCtD
Atomoxetine—Dizziness—Prednisone—rheumatoid arthritis	0.000182	0.000439	CcSEcCtD
Atomoxetine—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000182	0.000439	CcSEcCtD
Atomoxetine—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000182	0.000439	CcSEcCtD
Atomoxetine—Vomiting—Prednisone—rheumatoid arthritis	0.000175	0.000423	CcSEcCtD
Atomoxetine—Rash—Prednisone—rheumatoid arthritis	0.000174	0.000419	CcSEcCtD
Atomoxetine—Dermatitis—Prednisone—rheumatoid arthritis	0.000174	0.000419	CcSEcCtD
Atomoxetine—Nortriptyline—ALB—rheumatoid arthritis	0.000173	0.0147	CrCbGaD
Atomoxetine—Headache—Prednisone—rheumatoid arthritis	0.000173	0.000416	CcSEcCtD
Atomoxetine—Asthenia—Methotrexate—rheumatoid arthritis	0.000165	0.000398	CcSEcCtD
Atomoxetine—Nausea—Prednisone—rheumatoid arthritis	0.000164	0.000395	CcSEcCtD
Atomoxetine—Pruritus—Methotrexate—rheumatoid arthritis	0.000163	0.000393	CcSEcCtD
Atomoxetine—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000158	0.00038	CcSEcCtD
Atomoxetine—Dizziness—Methotrexate—rheumatoid arthritis	0.000152	0.000367	CcSEcCtD
Atomoxetine—Vomiting—Methotrexate—rheumatoid arthritis	0.000146	0.000353	CcSEcCtD
Atomoxetine—Rash—Methotrexate—rheumatoid arthritis	0.000145	0.00035	CcSEcCtD
Atomoxetine—Dermatitis—Methotrexate—rheumatoid arthritis	0.000145	0.00035	CcSEcCtD
Atomoxetine—Headache—Methotrexate—rheumatoid arthritis	0.000144	0.000348	CcSEcCtD
Atomoxetine—Nausea—Methotrexate—rheumatoid arthritis	0.000137	0.00033	CcSEcCtD
Atomoxetine—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	3.39e-05	0.000184	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	3.39e-05	0.000184	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CSF2—rheumatoid arthritis	3.38e-05	0.000184	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MMP3—rheumatoid arthritis	3.36e-05	0.000183	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—TYK2—rheumatoid arthritis	3.36e-05	0.000183	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—IL2RA—rheumatoid arthritis	3.36e-05	0.000182	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—MED1—rheumatoid arthritis	3.36e-05	0.000182	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MMP3—rheumatoid arthritis	3.33e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NCF2—rheumatoid arthritis	3.33e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—TYK2—rheumatoid arthritis	3.33e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—C3—rheumatoid arthritis	3.33e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CD28—rheumatoid arthritis	3.32e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MMP3—rheumatoid arthritis	3.26e-05	0.000177	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—TYK2—rheumatoid arthritis	3.26e-05	0.000177	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SH2B3—rheumatoid arthritis	3.25e-05	0.000177	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TRAF6—rheumatoid arthritis	3.25e-05	0.000177	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PTK2—rheumatoid arthritis	3.23e-05	0.000176	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—GZMB—rheumatoid arthritis	3.23e-05	0.000176	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.22e-05	0.000175	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PTK2—rheumatoid arthritis	3.21e-05	0.000174	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.2e-05	0.000174	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL5—rheumatoid arthritis	3.17e-05	0.000172	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL5—rheumatoid arthritis	3.15e-05	0.000171	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PTK2—rheumatoid arthritis	3.14e-05	0.000171	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL2—rheumatoid arthritis	3.13e-05	0.00017	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL3—rheumatoid arthritis	3.13e-05	0.00017	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—UBE2D1—rheumatoid arthritis	3.13e-05	0.00017	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.13e-05	0.00017	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CSF2—rheumatoid arthritis	3.12e-05	0.00017	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	3.12e-05	0.00017	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	3.12e-05	0.00017	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CSF2—rheumatoid arthritis	3.1e-05	0.000168	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCR5—rheumatoid arthritis	3.09e-05	0.000168	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL5—rheumatoid arthritis	3.08e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—IL2—rheumatoid arthritis	3.08e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL12—rheumatoid arthritis	3.07e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—BDKRB2—rheumatoid arthritis	3.07e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SAA1—rheumatoid arthritis	3.07e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—POMC—rheumatoid arthritis	3.06e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—IL2—rheumatoid arthritis	3.05e-05	0.000166	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—BGN—rheumatoid arthritis	3.05e-05	0.000166	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL2RA—rheumatoid arthritis	3.05e-05	0.000166	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	3.05e-05	0.000166	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6ST—rheumatoid arthritis	3.04e-05	0.000165	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CSF2—rheumatoid arthritis	3.04e-05	0.000165	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ADRBK1—rheumatoid arthritis	3.04e-05	0.000165	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—C3—rheumatoid arthritis	3.02e-05	0.000164	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NCF1—rheumatoid arthritis	3e-05	0.000163	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—IL2—rheumatoid arthritis	2.99e-05	0.000163	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	2.94e-05	0.00016	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SPP1—rheumatoid arthritis	2.94e-05	0.00016	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.92e-05	0.000159	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SPP1—rheumatoid arthritis	2.91e-05	0.000158	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.9e-05	0.000158	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CD28—rheumatoid arthritis	2.89e-05	0.000157	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TP53—rheumatoid arthritis	2.87e-05	0.000156	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RASGRP1—rheumatoid arthritis	2.86e-05	0.000156	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCR5—rheumatoid arthritis	2.86e-05	0.000155	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SYK—rheumatoid arthritis	2.85e-05	0.000155	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SPP1—rheumatoid arthritis	2.85e-05	0.000155	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.84e-05	0.000154	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCR5—rheumatoid arthritis	2.84e-05	0.000154	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL2RA—rheumatoid arthritis	2.82e-05	0.000153	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	2.81e-05	0.000153	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—BGN—rheumatoid arthritis	2.81e-05	0.000153	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PRKCQ—rheumatoid arthritis	2.8e-05	0.000152	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL2—rheumatoid arthritis	2.79e-05	0.000152	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL2RA—rheumatoid arthritis	2.79e-05	0.000152	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—C3—rheumatoid arthritis	2.79e-05	0.000152	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—POMC—rheumatoid arthritis	2.78e-05	0.000151	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCR5—rheumatoid arthritis	2.78e-05	0.000151	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL2—rheumatoid arthritis	2.77e-05	0.000151	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—C3—rheumatoid arthritis	2.77e-05	0.000151	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	2.77e-05	0.00015	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—STAT1—rheumatoid arthritis	2.75e-05	0.00015	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL2RA—rheumatoid arthritis	2.74e-05	0.000149	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCL2—rheumatoid arthritis	2.72e-05	0.000148	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—UBE2D1—rheumatoid arthritis	2.72e-05	0.000148	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL2—rheumatoid arthritis	2.72e-05	0.000148	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6R—rheumatoid arthritis	2.72e-05	0.000148	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—C3—rheumatoid arthritis	2.71e-05	0.000147	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL10—rheumatoid arthritis	2.71e-05	0.000147	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GC—rheumatoid arthritis	2.69e-05	0.000146	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	2.69e-05	0.000146	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL12—rheumatoid arthritis	2.67e-05	0.000145	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—BDKRB2—rheumatoid arthritis	2.67e-05	0.000145	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—POMC—rheumatoid arthritis	2.66e-05	0.000145	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6ST—rheumatoid arthritis	2.64e-05	0.000144	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ADRBK1—rheumatoid arthritis	2.64e-05	0.000143	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL6—rheumatoid arthritis	2.63e-05	0.000143	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—LEP—rheumatoid arthritis	2.6e-05	0.000141	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	2.58e-05	0.00014	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—LEP—rheumatoid arthritis	2.58e-05	0.00014	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—LEP—rheumatoid arthritis	2.53e-05	0.000137	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	2.5e-05	0.000136	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	2.49e-05	0.000135	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SYK—rheumatoid arthritis	2.48e-05	0.000135	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MMP3—rheumatoid arthritis	2.47e-05	0.000134	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—TYK2—rheumatoid arthritis	2.47e-05	0.000134	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.47e-05	0.000134	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—FN1—rheumatoid arthritis	2.45e-05	0.000133	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6ST—rheumatoid arthritis	2.44e-05	0.000133	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—FN1—rheumatoid arthritis	2.43e-05	0.000132	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	2.43e-05	0.000132	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6ST—rheumatoid arthritis	2.42e-05	0.000132	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—POMC—rheumatoid arthritis	2.42e-05	0.000131	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—STAT1—rheumatoid arthritis	2.39e-05	0.00013	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—FN1—rheumatoid arthritis	2.38e-05	0.000129	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PTK2—rheumatoid arthritis	2.38e-05	0.000129	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6ST—rheumatoid arthritis	2.37e-05	0.000129	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCL8—rheumatoid arthritis	2.37e-05	0.000129	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL2—rheumatoid arthritis	2.36e-05	0.000129	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6R—rheumatoid arthritis	2.36e-05	0.000128	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL10—rheumatoid arthritis	2.36e-05	0.000128	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CD80—rheumatoid arthritis	2.35e-05	0.000128	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL5—rheumatoid arthritis	2.34e-05	0.000127	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CD80—rheumatoid arthritis	2.33e-05	0.000127	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CSF2—rheumatoid arthritis	2.3e-05	0.000125	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	2.29e-05	0.000125	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CD80—rheumatoid arthritis	2.28e-05	0.000124	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—IL2—rheumatoid arthritis	2.27e-05	0.000123	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.25e-05	0.000122	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—POMC—rheumatoid arthritis	2.23e-05	0.000121	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—POMC—rheumatoid arthritis	2.22e-05	0.00012	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—MED1—rheumatoid arthritis	2.19e-05	0.000119	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL2—rheumatoid arthritis	2.18e-05	0.000119	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6R—rheumatoid arthritis	2.18e-05	0.000118	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—POMC—rheumatoid arthritis	2.17e-05	0.000118	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL2—rheumatoid arthritis	2.17e-05	0.000118	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SPP1—rheumatoid arthritis	2.16e-05	0.000118	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6R—rheumatoid arthritis	2.16e-05	0.000117	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.15e-05	0.000117	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MMP3—rheumatoid arthritis	2.15e-05	0.000117	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—TYK2—rheumatoid arthritis	2.15e-05	0.000117	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL2—rheumatoid arthritis	2.12e-05	0.000115	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6R—rheumatoid arthritis	2.12e-05	0.000115	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	2.11e-05	0.000115	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCR5—rheumatoid arthritis	2.1e-05	0.000114	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL2RA—rheumatoid arthritis	2.07e-05	0.000113	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PTK2—rheumatoid arthritis	2.07e-05	0.000112	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	2.06e-05	0.000112	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL2—rheumatoid arthritis	2.06e-05	0.000112	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—C3—rheumatoid arthritis	2.06e-05	0.000112	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	2.04e-05	0.000111	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	2.04e-05	0.000111	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL5—rheumatoid arthritis	2.03e-05	0.00011	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CSF2—rheumatoid arthritis	2e-05	0.000109	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TYK2—rheumatoid arthritis	1.98e-05	0.000108	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.97e-05	0.000107	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TYK2—rheumatoid arthritis	1.97e-05	0.000107	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—IL2—rheumatoid arthritis	1.97e-05	0.000107	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NOS3—rheumatoid arthritis	1.95e-05	0.000106	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NOS3—rheumatoid arthritis	1.93e-05	0.000105	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TYK2—rheumatoid arthritis	1.93e-05	0.000105	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—LEP—rheumatoid arthritis	1.91e-05	0.000104	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NOS3—rheumatoid arthritis	1.89e-05	0.000103	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SPP1—rheumatoid arthritis	1.88e-05	0.000102	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.87e-05	0.000102	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—BGN—rheumatoid arthritis	1.84e-05	9.98e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCR5—rheumatoid arthritis	1.83e-05	9.93e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—FN1—rheumatoid arthritis	1.8e-05	9.81e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.8e-05	9.79e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6ST—rheumatoid arthritis	1.8e-05	9.77e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL2—rheumatoid arthritis	1.79e-05	9.71e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—C3—rheumatoid arthritis	1.79e-05	9.7e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CD80—rheumatoid arthritis	1.73e-05	9.41e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCL8—rheumatoid arthritis	1.73e-05	9.39e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCL8—rheumatoid arthritis	1.71e-05	9.32e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.69e-05	9.19e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCL8—rheumatoid arthritis	1.68e-05	9.12e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	1.66e-05	9.03e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL2—rheumatoid arthritis	1.65e-05	8.97e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CAT—rheumatoid arthritis	1.65e-05	8.96e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—POMC—rheumatoid arthritis	1.64e-05	8.94e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6—rheumatoid arthritis	1.64e-05	8.93e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL2—rheumatoid arthritis	1.64e-05	8.9e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6—rheumatoid arthritis	1.63e-05	8.86e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL2—rheumatoid arthritis	1.61e-05	8.74e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6R—rheumatoid arthritis	1.6e-05	8.72e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL2—rheumatoid arthritis	1.6e-05	8.72e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6—rheumatoid arthritis	1.6e-05	8.67e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	1.57e-05	8.52e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MMP9—rheumatoid arthritis	1.56e-05	8.49e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.56e-05	8.49e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MMP9—rheumatoid arthritis	1.55e-05	8.43e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NFKB1—rheumatoid arthritis	1.55e-05	8.4e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NFKB1—rheumatoid arthritis	1.53e-05	8.34e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MAPK8—rheumatoid arthritis	1.52e-05	8.26e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MMP9—rheumatoid arthritis	1.52e-05	8.25e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.52e-05	8.24e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MAPK8—rheumatoid arthritis	1.51e-05	8.2e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	1.5e-05	8.17e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NFKB1—rheumatoid arthritis	1.5e-05	8.16e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MAPK8—rheumatoid arthritis	1.48e-05	8.02e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TYK2—rheumatoid arthritis	1.46e-05	7.94e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.43e-05	7.79e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	1.43e-05	7.76e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—VEGFA—rheumatoid arthritis	1.4e-05	7.63e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.4e-05	7.59e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.39e-05	7.57e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—VEGFA—rheumatoid arthritis	1.39e-05	7.57e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.38e-05	7.49e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	1.38e-05	7.48e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—VEGFA—rheumatoid arthritis	1.36e-05	7.41e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TGFB1—rheumatoid arthritis	1.29e-05	7e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TGFB1—rheumatoid arthritis	1.28e-05	6.95e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	1.27e-05	6.91e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	1.27e-05	6.9e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.27e-05	6.88e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TGFB1—rheumatoid arthritis	1.25e-05	6.8e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.25e-05	6.77e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	1.22e-05	6.61e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	1.21e-05	6.57e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	1.15e-05	6.25e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	1.14e-05	6.19e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	1.12e-05	6.08e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.1e-05	6e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—POMC—rheumatoid arthritis	1.1e-05	5.98e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TP53—rheumatoid arthritis	1.06e-05	5.76e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	1.06e-05	5.74e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TP53—rheumatoid arthritis	1.05e-05	5.72e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	1.05e-05	5.71e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	1.03e-05	5.62e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TP53—rheumatoid arthritis	1.03e-05	5.6e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—POMC—rheumatoid arthritis	1.01e-05	5.5e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALB—rheumatoid arthritis	1e-05	5.45e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	9.99e-06	5.43e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CAT—rheumatoid arthritis	9.92e-06	5.39e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	9.88e-06	5.37e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	9.72e-06	5.28e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6—rheumatoid arthritis	9.7e-06	5.27e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6—rheumatoid arthritis	9.63e-06	5.23e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	9.6e-06	5.22e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	9.48e-06	5.15e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6—rheumatoid arthritis	9.43e-06	5.12e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALB—rheumatoid arthritis	9.23e-06	5.02e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	8.97e-06	4.88e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	8.83e-06	4.8e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	8.78e-06	4.77e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	8.28e-06	4.5e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	8.23e-06	4.48e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	8.07e-06	4.39e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	7.81e-06	4.24e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	7.14e-06	3.88e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	6.78e-06	3.68e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—POMC—rheumatoid arthritis	6.62e-06	3.6e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	6.2e-06	3.37e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALB—rheumatoid arthritis	6.03e-06	3.28e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	5.77e-06	3.14e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	5.28e-06	2.87e-05	CbGpPWpGaD
